ADMA BIOLOGICS, INC. Other Nonoperating Expense
ADMA BIOLOGICS, INC. (ADMA) reported Other Nonoperating Expense of $83.32 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-08-11.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2021-08-11
- ADMA BIOLOGICS, INC. other nonoperating expense for the quarter ending 2021-06-30 was $83.32K, a 1207.75% increase year-over-year.
- ADMA BIOLOGICS, INC. other nonoperating expense for the quarter ending 2020-06-30 was $6.37K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month |
|---|---|---|
| 2021-06-30 | $83.32K 10-Q · filed 2021-08-11 | $125.32K 10-Q · filed 2021-08-11 |
| 2020-06-30 | $6.37K 10-Q · filed 2021-08-11 | $12.79K 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |